2012
DOI: 10.1590/s0103-507x2012000200004
|View full text |Cite
|
Sign up to set email alerts
|

À procura do Santo Graal: aonde vamos com os biomarcadores na sepse?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…These markers can be divided into risk prediction, diagnosis, monitoring and outcome. ( 7,8 ) In this group of molecules, we can highlight the success of some, such as procalcitonin and CD14, ( 7,9 ) but they are costly and not feasible options for low- and middle-income countries, such as Brazil.…”
Section: Introductionmentioning
confidence: 99%
“…These markers can be divided into risk prediction, diagnosis, monitoring and outcome. ( 7,8 ) In this group of molecules, we can highlight the success of some, such as procalcitonin and CD14, ( 7,9 ) but they are costly and not feasible options for low- and middle-income countries, such as Brazil.…”
Section: Introductionmentioning
confidence: 99%
“…Sepsis is one of the main causes of mortality and extended length of stay in patients with urological infections, including Fournier gangrene [20] . To reduce the severity of the disease, utilization of cheap and simple laboratory parameters, such as white blood cell parameters, erythrocyte sedimentation rate, and C-reactive protein are necessary [21,22] . The use of NLR as a parameter has been suggested by many studies.…”
Section: Discussionmentioning
confidence: 99%